Singapore markets closed
Straits Times Index
3,319.55 +11.65 (+0.35%) S&P 500
5,307.01 -14.40 (-0.27%) Dow
39,671.04 -201.95 (-0.51%) Nasdaq
16,801.54 -31.08 (-0.18%) Bitcoin USD
69,794.45 -209.61 (-0.30%) CMC Crypto 200
1,502.32 -0.35 (-0.02%)
BeiGene, Ltd. (6160.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
At close: 04:08PM HKT
| Previous close | 102.700 |
| Open | 101.500 |
| Bid | 97.700 x 0 |
| Ask | 97.800 x 0 |
| Day's range | 96.900 - 101.500 |
| 52-week range | 75.450 - 145.400 |
| Volume | |
| Avg. volume | 1,443,941 |
| Market cap | 137.196B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.520 |
| Earnings date | 31 Jul 2024 - 07 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 167.83 |
ZacksBeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why
Beigene's (BGNE) shares surge 32% in a month due to the label expansion of one of its key oncology drugs, Tevimbra, to treat three NSCLC indications, including first- and second-line use, in the EU.
Business WireBeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024
SAN MATEO, Calif., May 14, 2024--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data from its hematology portfolio and pipeline at the European Hematology Association 2024 Hybrid Congress (EHA2024) in Madrid, Spain, June 13-16, 2024. BeiGene has 28 abstracts accepted at EHA2024, with four scheduled for oral presentations.
Simply Wall St.The BeiGene, Ltd. (NASDAQ:BGNE) First-Quarter Results Are Out And Analysts Have Published New Forecasts
A week ago, BeiGene, Ltd. ( NASDAQ:BGNE ) came out with a strong set of quarterly numbers that could potentially lead...
© 2024 Yahoo. All rights reserved.